Responses
Regular and young investigator award abstracts
Clinical trials completed
264 Correlation of virus-specific CD8+ T cells to clinical response following treatment with Pexa-Vec and Cemiplimab in patients with advanced renal cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
